Holen Sie sich die Stockscreener-App
1.685
0.88%
-0.015
Schlusskurs vom Vortag:
$1.70
Offen:
$1.68
24-Stunden-Volumen:
101.81K
Relative Volume:
0.09
Marktkapitalisierung:
$126.81M
Einnahmen:
$302.48M
Nettoeinkommen (Verlust:
$-265.26M
KGV:
-0.4534
EPS:
-3.716
Netto-Cashflow:
$-2.76M
1W Leistung:
-0.30%
1M Leistung:
-2.60%
6M Leistung:
-11.78%
1J Leistung:
-50.44%
1-Tages-Spanne:
$1.65
$1.70
1-Wochen-Bereich:
$1.58
$1.75
52-Wochen-Spanne:
$0.9551
$3.615
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, BTSG, TEM, TXG, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
1.685 | 127.94M | 302.48M | -265.26M | -2.76M | -3.716 |
VEEV
Veeva Systems Inc
|
262.67 | 42.88B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
61.33 | 12.38B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
62.77 | 11.67B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
64.59 | 8.55B | 638.78M | -22.66M | 122.18M | -0.1744 |
HQY
Healthequity Inc
|
93.54 | 7.72B | 1.34B | 230.70M | 440.96M | 2.6695 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-18 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-08-27 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-10-14 | Eingeleitet | BTIG Research | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-06-18 | Eingeleitet | Stifel | Buy |
| 2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
| 2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-19 | Eingeleitet | Goldman | Buy |
| 2019-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-19 | Eingeleitet | SunTrust | Buy |
| 2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
symbol__ Stock Quote Price and Forecast - cnn.com
Investor group asks for clearer plan at Health Catalyst (NASDAQ: HCAT) - Stock Titan
Health Catalyst taps new CEO - Modern Healthcare
Health Catalyst, Inc. Announces CEO Changes - marketscreener.com
Health Catalyst Appoints Simeon Kohl as CEO, Ben Albert Steps Down - Minichart
Health Catalyst names Simeon Kohl as new CEO By Investing.com - Investing.com Canada
Health Catalyst appoints Simeon Kohl as new CEO - TipRanks
The Next Healthcare Catalyst Hunt Is On — Why Knight Therapeutics, Inc. (TSX:GUD) Could Draw Attention - kalkine.ca
Health Catalyst names Simeon Kohl as new CEO - Investing.com
Health Catalyst gets a new chief after he led a healthcare company through a roughly $670 million sale. - Stock Titan
The Next Healthcare Catalyst Hunt Is On — Why HLS Therapeutics, Inc. (HLS) Could Draw Attention - kalkine.ca
Health Catalyst Grants Insider Julie Larson-Green 9,766 Shares at No Cost (NASDAQ: HCAT) - kalkinemedia.com
Health Catalyst | 4: Statement of changes in beneficial ownership of securities-Officer Alger Jason - Moomoo
Health Catalyst | 4: Statement of changes in beneficial ownership of securities-Director Larson-Green Julie - Moomoo
Health Catalyst (HCAT) CEO offloads 321 shares to cover taxes - Stock Titan
Health Catalyst (HCAT) CFO sells shares to cover RSU taxes - Stock Titan
Equity grant lifts Health Catalyst (HCAT) director to 185K shares - Stock Titan
Tax-driven stock sale by Health Catalyst (HCAT) legal chief - Stock Titan
Health Catalyst (NASDAQ: HCAT) officer schedules new stock sale after June trades - Stock Titan
Health Catalyst (HCAT) insider plans $30,618.80 stock sale - Stock Titan
Health Catalyst (NASDAQ: HCAT) executive lines up stock sale; size and timing inside - Stock Titan
Health Catalyst to Participate in Upcoming Investor Conference - The Manila Times
Health Catalyst Market Sentiment - Benzinga España
Health Catalyst Inc (HCAT) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Investors Are Hunting for the Next Healthcare Catalyst: Could HLS Therapeutics, Inc (HLS) Deliver? - kalkine.ca
The Global Health Catalyst Summit 2026 - Oncodaily
Health Catalyst Shares Fall After Canaccord Genuity Downgrade - marketscreener.com
This Teradyne Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga
HCAT Downgraded by Canaccord Genuity -- Price Target Lowered to $1.80 - GuruFocus
HCAT Looks 60.3% Undervalued on GF Value™ Despite Market Concerns - GuruFocus
Health Catalyst (HCAT) Q2 2026 Earnings Call Transcript - AOL.com
Health Catalyst, GitLab, Elastic, and Marqeta Shares Plummet, What You Need To Know - Yahoo Finance
5 Must-Read Analyst Questions From Health Catalyst’s Q2 Earnings Call - Yahoo Finance
Health Catalyst (HCAT) group led by Clint Coghill reports 9.6% ownership stake - Stock Titan
HCAT Maintains by Wells Fargo -- Price Target Lowered to $1.50 - GuruFocus
Wells Fargo & Company Has Lowered Expectations for Health Catalyst (NASDAQ:HCAT) Stock Price - MarketBeat
Health Catalyst sells VitalWare for $147Mn - Outsource Accelerator
Health Catalyst, Inc. (NASDAQ:HCAT) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Health Catalyst: Q2 Earnings Snapshot - AOL.com
HCAT Maintained by Citigroup -- Price Target Lowered to $2.00 - GuruFocus
Health Catalyst (NASDAQ:HCAT) Price Target Cut to $2.00 by Analysts at Citigroup - MarketBeat
HCAT Q2 Deep Dive: Vitalware Divestiture Reshapes Strategy Amid Revenue Decline - Yahoo Finance
Why Health Catalyst (HCAT) Shares Are Trading Lower Today - finance.yahoo.com
Health Catalyst (NASDAQ:HCAT) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Health Catalyst Shares Tumble Overnight: What Investors Need to Know - webull.com
Health Catalyst, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Health Catalyst sells Vitalware unit, retires credit facility By Investing.com - Investing.com Nigeria
Health Catalyst Inc (HCAT) (Q2 2026) Earnings Call Highlights: D - GuruFocus
Health Catalyst 2Q Loss $40.5M >HCAT - Moomoo
Health Catalyst Reports Second Quarter 2026 Results - The Manila Times
Is Health Catalyst Inc (HCAT) Positioned for Recovery After Q2 E - GuruFocus
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.63%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):